Annual Revenue
$35.67 M
+$8.45 M+31.06%
December 31, 2022
Summary
- As of February 10, 2025, NBRV annual revenue is $35.67 million, with the most recent change of +$8.45 million (+31.06%) on December 31, 2022.
- During the last 3 years, NBRV annual revenue has risen by +$27.92 million (+360.35%).
Performance
NBRV Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$7.59 M
-$2.85 M-27.29%
March 31, 2023
Summary
- As of February 10, 2025, NBRV quarterly revenue is $7.59 million, with the most recent change of -$2.85 million (-27.29%) on March 31, 2023.
- Over the past year, NBRV quarterly revenue has dropped by -$79.00 thousand (-1.03%).
Performance
NBRV Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$35.59 M
-$79.00 K-0.22%
March 31, 2023
Summary
- As of February 10, 2025, NBRV TTM revenue is $35.59 million, with the most recent change of -$79.00 thousand (-0.22%) on March 31, 2023.
- Over the past year, NBRV TTM revenue has increased by +$2.84 million (+8.66%).
Performance
NBRV TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
NBRV Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +31.1% | -1.0% | +8.7% |
3 y3 years | +360.4% | +2421.6% | +404.9% |
5 y5 years | - | +16.8% | +359.3% |
NBRV Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | -23.7% | -27.3% | at low | -0.2% | -23.5% |
5 y | 5-year | at high | -92.0% | -27.3% | -100.5% | -0.2% | -97.0% |
alltime | all time | at high | -92.0% | -27.3% | -100.5% | -0.2% | -97.2% |
Nabriva Therapeutics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | $7.59 M(-27.3%) | $35.59 M(-0.2%) |
Dec 2022 | $35.67 M(+31.1%) | $10.44 M(+18.8%) | $35.67 M(+4.5%) |
Sep 2022 | - | $8.78 M(+0.1%) | $34.14 M(+1.1%) |
Jun 2022 | - | $8.78 M(+14.4%) | $33.78 M(+3.1%) |
Mar 2022 | - | $7.67 M(-13.9%) | $32.75 M(+20.3%) |
Dec 2021 | $27.22 M(+850.3%) | $8.91 M(+5.8%) | $27.22 M(+33.8%) |
Sep 2021 | - | $8.42 M(+8.6%) | $20.34 M(+62.9%) |
Jun 2021 | - | $7.75 M(+263.6%) | $12.49 M(+166.0%) |
Mar 2021 | - | $2.13 M(+4.8%) | $4.70 M(+63.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | $2.86 M(-63.0%) | $2.04 M(+257.6%) | $2.86 M(+164.9%) |
Sep 2020 | - | $569.00 K(-1487.8%) | $1.08 M(-84.6%) |
Jun 2020 | - | -$41.00 K(-113.6%) | $7.01 M(-0.6%) |
Mar 2020 | - | $301.00 K(+19.4%) | $7.05 M(-9.0%) |
Dec 2019 | $7.75 M(+19.2%) | $252.00 K(-96.1%) | $7.75 M(+3.4%) |
Sep 2019 | - | $6.50 M(+549.6%) | $7.50 M(+649.6%) |
Mar 2019 | - | $1.00 M(-84.6%) | $1.00 M(-84.6%) |
Dec 2018 | $6.50 M | - | - |
Mar 2018 | - | $6.50 M | $6.50 M |
FAQ
- What is Nabriva Therapeutics annual revenue?
- What is the all time high annual revenue for Nabriva Therapeutics?
- What is Nabriva Therapeutics annual revenue year-on-year change?
- What is Nabriva Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Nabriva Therapeutics?
- What is Nabriva Therapeutics quarterly revenue year-on-year change?
- What is Nabriva Therapeutics TTM revenue?
- What is the all time high TTM revenue for Nabriva Therapeutics?
- What is Nabriva Therapeutics TTM revenue year-on-year change?
What is Nabriva Therapeutics annual revenue?
The current annual revenue of NBRV is $35.67 M
What is the all time high annual revenue for Nabriva Therapeutics?
Nabriva Therapeutics all-time high annual revenue is $35.67 M
What is Nabriva Therapeutics annual revenue year-on-year change?
Over the past year, NBRV annual revenue has changed by +$8.45 M (+31.06%)
What is Nabriva Therapeutics quarterly revenue?
The current quarterly revenue of NBRV is $7.59 M
What is the all time high quarterly revenue for Nabriva Therapeutics?
Nabriva Therapeutics all-time high quarterly revenue is $10.44 M
What is Nabriva Therapeutics quarterly revenue year-on-year change?
Over the past year, NBRV quarterly revenue has changed by -$79.00 K (-1.03%)
What is Nabriva Therapeutics TTM revenue?
The current TTM revenue of NBRV is $35.59 M
What is the all time high TTM revenue for Nabriva Therapeutics?
Nabriva Therapeutics all-time high TTM revenue is $35.67 M
What is Nabriva Therapeutics TTM revenue year-on-year change?
Over the past year, NBRV TTM revenue has changed by +$2.84 M (+8.66%)